Stress doppler echocardiography in connective tissue disease patients without overt pulmonary arterial hypertension

被引:0
作者
李贺智 [1 ]
雷云霞 [1 ]
侯乐正 [1 ]
罗冬玲 [1 ]
张曹进 [1 ]
费洪文 [1 ]
机构
[1] Cardiology Department, Guangdong Cardiovascular Institute,Guangdong General Hospital
关键词
stress doppler echocardiography; connective tissue disease; pulmonary arterial hypertension;
D O I
10.16268/j.cnki.44-1512/r.2019.01.005
中图分类号
R544.1 [高血压]; R593.2 [自身免疫性疾病、结缔组织疾病];
学科分类号
1002 ; 100201 ;
摘要
Background Pulmonary arterial hypertension(PAH) is a common complication of connective tissue disease(CTD) and confers a worse prognosis. Stress doppler echocardiography(SDE) can detect early pulmonary vasculopathy and assess right heart function in patients with pulmonary arterial hypertension. In this study, the SDE was applied to analyze the degree of pulmonary vascular lesion and the function of right heart in CTD patients without overt PAH. Methods CTD patients without overt PAH were divided into exercised-induced pulmonary hypertension(EIPH) group and non-EIPH group depending on whether tricuspid regurgitation(TR) exceeded 3.1 m/s during exercise and assessed by echocardiography at rest and during exercise. The data of right ventricular function and the slope of the incremental of the mean pulmonary artery pressure and cardiac output(ΔmPAP/ΔCO) were analyzed. Results Forty-seven CTD patients without overt PAH(35 female, mean age 40.3±12.0 years) were enrolled and divided into EIPH group(n=21) and non-EIPH group(n=26). Patients with systemic sclerosis(SSc) were more likely to have EIPH(47.6% vs. 28.6%, P<0.05) than those with systemic lupus erythematosus(SLE). Patients in EIPH group had a higher value of ΔmPAP/ΔCO than that of the non-EIPH group(4.5±3.1 vs. 2.2±1.3, P<0.05). SSc was more prevalent in CTD patients and the symptoms of dyspnea occurred more often in EIPH group(52.4%), indicating a pressure-flow mismatch induced by exercise. However, the cardiac function demonstrated by left ventricular ejection fraction(LVEF), tricuspid annular plane systolic excursion(TAPSE),DTI-Derived S’-wave velocity(S’) and right ventricular fractional area change(RVFAC), as well as functional reserve reflected by the changes of TAPSE, S’, RVFAC before and after exercise, did not differ significantly between the two groups. Conclusions Although right ventricular(RV) reserve function does not change much before and after exercise, patients in EIPH group have a higher value of ΔmPAP/ΔCO than that of the non-EIPH group and more likely to have symptoms during exercise. Thus, to assess the potential for pulmonary vascular disease, echocardiography should be performed at rest and during exercise.[S Chin J Cardiol 2019;20(1):31-36]
引用
收藏
页码:31 / 36
页数:6
相关论文
共 15 条
  • [1] Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J] . Roberto M. Lang,Luigi P. Badano,Victor Mor-Avi,Jonathan Afilalo,Anderson Armstrong,Laura Ernande,Frank A. Flachskampf,Elyse Foster,Steven A. Goldstein,Tatiana Kuznetsova,Patrizio Lancellotti,Denisa Muraru,Michael H. Picard,Ernst R. Rietzschel,Lawrence Rudski,Kirk T. Spencer,Wendy Tsang,Jens-Uwe Voigt.
  • [2] 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension
    Galie, Nazzareno
    Humbert, Marc
    Vachiery, Jean-Luc
    Gibbs, Simon
    Lang, Irene
    Torbicki, Adam
    Simonneau, Gerald
    Peacock, Andrew
    Noordegraaf, Anton Vonk
    Beghetti, Maurice
    Ghofrani, Ardeschir
    Sanchez, Miguel Angel Gomez
    Hansmann, Georg
    Klepetko, Walter
    Lancellotti, Patrizio
    Matucci, Marco
    McDonagh, Theresa
    Pierard, Luc A.
    Trindade, Pedro T.
    Zompatori, Maurizio
    Hoeper, Marius
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (02): : 177 - 177
  • [3] The Clinical Use of Stress Echocardiography in Non-Ischaemic Heart Disease: Recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography[J] . Patrizio Lancellotti,Patricia A. Pellikka,Werner Budts,Farooq A. Chaudhry,Erwan Donal,Raluca Dulgheru,Thor Edvardsen,Madalina Garbi,Jong Won Ha,Garvan C. Kane,Joe Kreeger,Luc Mertens,Philippe Pibarot,Eugenio Picano,Thomas Ryan,Jeane M. Tsutsui,Albert Varga. &nbspJournal of the American Society of Echo
  • [4] Inappropriate exercise-induced increase in pulmonary artery pressure in patients with systemic sclerosis. Michele D’Alto,Stefano Ghio,Antonello D’Andrea,Anna Sara Pazzano,Paola Argiento,Rita Camporotondo,Francesca Allocca,Laura Scelsi,Giovanna Cuomo,Roberto Caporali,Lorenzo Cavagna,Gabriele Valentini,Raffaele Calabrograv. Heart . 2011
  • [5] Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis:the DETECT study. Coghlan JG,Denton CP,Grünig E,Bonderman D,Distler O,Khanna D,Müller-Ladner U,Pope JE,Vonk MC,Doelberg M,Chadha-Boreham H,Heinzl H,Rosenberg DM,McLaughlin VV,Seibold JR. Annals of the Rheumatic Diseases . 2014
  • [6] Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. Pope Janet E,Lee Peter,Baron Murray,Dunne James,Smith Douglas,Docherty Peter S,Bookman Arthur,Abu-Hakima Maysan. The Journal of rheumatology . 2005
  • [7] Rest and exercise echocardiography for early detection of pulmonary hypertension. Kusunose K,Yamada H. J Echocardiogr . 2016
  • [8] Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. Hsu Vivien M,Moreyra Abel E,Wilson Alan C,Shinnar Meir,Shindler Daniel M,Wilson Julianne E,Desai Ami,Seibold James R. The Journal of rheumatology . 2008
  • [9] Risk factorsfor death and the 3-year survival of patients with sys-temic sclerosis:the French ItinérAIR-Sclérodermie study. Hachulla E,Carpentier P,Gressin V,et al. Rheumatology . 2009
  • [10] Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial[J] . N Galiè,LJ Rubin,MM Hoeper,P Jansa,H Al-Hiti,GMB Meyer,E Chiossi,A Kusic-Pajic,G Simonneau. &nbspThe Lancet . 2008 (9630)